Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Neurology|May 26, 2022
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related SynucleinopathiesSindhu Menon, Sabrina Armstrong, Amir Hamzeh, et al.
Journal of Parkinson'S Disease|October 12, 2013
Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophyNaomi P Visanji, Joanna F Collingwood, Mary E Finnegan, et al.
The Journal of Biological Chemistry|March 13, 2009
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fissionRuben K Dagda, Salvatore J Cherra, Scott M Kulich, et al.
The Journal of Biological Chemistry|August 19, 2011
Effect of Ser-129 phosphorylation on interaction of α-synuclein with synaptic and cellular membranesNaomi P Visanji, Sabine Wislet-Gendebien, Loren W Oschipok, et al.
Bioanalysis|May 19, 2011
Metabolomics: a second-generation platform for crop and food analysisLouise Vt Shepherd, Paul Fraser, Derek Stewart
Nature|April 28, 2006
TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activityFusheng Chen, Hiroshi Hasegawa, Gerold Schmitt-Ulms, et al.
Trends in Neurosciences|November 8, 2016
α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New EraNaomi P Visanji, Jonathan M Brotchie, Lorraine V Kalia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2026
Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's DiseaseRikke Hahn Kofoed, Victor Schwartz Hvingelby, Jose A Pineda-Pardo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 18, 2015
Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's DiseaseÉliane Proulx, Paul Fraser, JoAnne McLaurin, et al.
Pageof 9